Company Filing History:
Years Active: 2003-2010
Title: The Innovative Contributions of Robert Donald
Introduction
Robert Donald is a notable inventor based in South Orange, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the development of antiprotozoal agents. With a total of 3 patents, his work has the potential to impact therapeutic strategies against protozoal infections.
Latest Patents
Robert Donald's latest patents include groundbreaking research on Toxoplasma gondii cyclic GMP dependent protein kinase G as a chemotherapeutic target for antiprotozoal agents. This patent highlights the isolation and cloning of protozoal cyclic GMP dependent protein kinases, which may be utilized in screening assays to identify potential antiprotozoal agents. Additionally, he has developed another patent focusing on cyclic GMP dependent protein kinase as a chemotherapeutic target for antiprotozoal agents, emphasizing the same innovative approach to combating protozoal infections.
Career Highlights
Throughout his career, Robert has worked with prominent companies such as Merck & Company, Inc. and Merial Limited. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical research.
Collaborations
Some of Robert's notable coworkers include Anne M. Gurnett and Paul A. Liberator. Their collaborative efforts have further enriched the research landscape in which Robert operates.
Conclusion
Robert Donald's innovative work in the field of biochemistry, particularly regarding antiprotozoal agents, showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to improving therapeutic options for infectious diseases.